D. Bradley Welling, MD, PhD

D. Bradley Welling, MD, PhD, FACS, is a member of the Department of Otolaryngology at Nationwide Children’s Hospital and a Professor and Chair of the Department of Otolaryngolgy – Head and Neck Surgery at The Ohio State University College of Medicine. His research interests include the genetics and treatment of vestibular schwannomas and the molecular characteristics of the Neurofibromatosis Type 2 gene. He received a K08 to study and identify mutations with the NF2 gene and an R01 award from the National Institute of Health Deafness and Communication Disorders to further characterize the phenotypic determinants in vestibular schwannomas. He is a co-investigator with Dr. Gregory Wiet on the development and validation of the virtual temporal bone dissector model also funded by the NIH/ DCD. Dr. Welling was the co-principal investigator on a study of post-transcriptional regulation of the neurofibromatosis gene with Long-Sheng Chang, PhD. He has received numerous honors including the Edmund Prince Fowler Award for his Triologic Thesis “Clinical Manifestations of Mutations in the Neurofibromatosis Type 2 Gene in Vestibular Schwannomas (Acoustic Neuromas)” and the Nicholas Torok Award in Vestibular Science for “cDNA Microarray Analysis of Vestibular Schwannomas” by the American Neurotology Society. Dr. Welling was named a Daiichi Clinical Scholar in Clinical Research and Evidence Based Medicine and received the American Academy of Otolaryngology – Head and Neck Surgery’s Honor Award. He was awarded the Department Teaching Award in 2005 and was honored to be inducted in 2006 to the Collegium Oto-Rhino-Laryngologicum Amicitiae Sacrum, which is an international honorary society for researchers. He is the President Elect of the American Neurotology Society and is Vice President of the Board of Directors of the Otology & Neurotology Journal. He has served as a Senior Examiner for the American Board of Otolaryngology and is the secretary-treasurer of the Middle Section of the Triologic Society. Dr. Welling has authored 65 peer-reviewed articles and 17 book chapters. He is the invited keynote speaker for the 5th International Convention on Vestibular Schwannomas and Other CPA tumors in Barcelona, Spain, and was honored last September as the guest of honor for the Japan Otologic Society. Clinically, Dr. Welling is interested in all aspects of ear and hearing disease in children and adults. As a preceptor, Dr. Welling works with medical students who are interested in clinical and basic research in otology and neurotology.

Gender:

• Male

Languages Spoken:

• English
• Japanese

Research Funding*:

• Phenotypic Determinants of Vestibular Schwannomas, National Institutes of Health, Deafness and Communications Disorders
• 
  Post-Transcriptional Regulation of the Neurofibromatosis Gene, DB United States Army Research and Material Command

Medical School

• University of Utah
  Date Completed: 06/30/1983

Internship

• University of Iowa
  Date Completed: 06/30/1984

Residency

• University of Iowa
  Date Completed: 06/30/1988

Fellowship

• Ear Foundation
  Date Completed: 06/30/1989

Department:

• Otolaryngology

Speciality:

• Neurotology
  
• Otolaryngology
  

Date of Appointment at Nationwide Children’s Hospital:

• 03/20/1990

• Husein OF, Jacob A, Massick DD, Welling DB. Recurrence of isolated multiple myeloma in the skull base: a case report and review of the literature. (Review) Ear Nose Throat Journal 86(9): 555-60, September 2007.
• Jacob A, Robinson LL Jr, Bortman JS, Yu L, Dodson EE, Welling DB. Nerve of Origin, Tumor Size, Hearing Preservation, and Facial Nerve Outcomes in 359 Vestibular Schwannoma Resections at a Tertiary Care Academic Center. Laryngoscope, October 4, 2007.
• Jacob A, Bortman JS, Robinson Jr. LL, Yu L, Dodson EE, Welling DB. Does packing the Eustachian tube impact cerebrospinal fluid rhinorrhea rates in translabyrinthine vestibular schwannomas resections? Otology and Neurotology 28(7): 934-8, October 2007.
• Jacob A, Brightman RP, Welling DB. Bilateral cerebellopontine angle metastatic melanoma: a case report. Ear Nose Throat Journal 86(7): 388-90, July 2007.
• Neff BA, Wiet RM, Lasak JM, Cohen NL, Pillsbury HC, Ramsden RT, Welling DB. Cochlear implantation in the neurofibromatosis type 2 patient: long-term followup. Laryngoscope 117(6): 1069-72, June 2007.
• Otto BA, Jacob A, Klein MJ, Welling DB. Chondromyxoid fibroma of the temporal bone: case report and review of the literature. Annals of Otology, Rhinology & Laryngology 116(12): 922-7, December 2007.
• Welling DB. Long-term follow-up of hearing loss in biotinidase deficiency. Journal of Child Neurology 22(8): 1055, August 2007.
• Welling DB, Packer MD, Chang LS. Molecular studies of vestibular schwannomas: a review. Current Opinion in Otolaryngology & Head and Neck Surgery (review) 15(5): 341-6, October 2007.

• Listed, Best Doctors in America